Below are the most recent publications written about "Chlamydia Infections" by people in Profiles.
-
Sharma V, Khan MM. Current Progress and Future Perspective of Chlamydia trachomatis Infection: A Rising Threat to Women Health. Curr Microbiol. 2025 May 29; 82(7):314.
-
Richardson S, Medhavi FNU, Tanner T, Lundy S, Omosun Y, Igietseme JU, Eko FO. Role of route of delivery on Chlamydia abortus vaccine-induced immune responses and genital tract immunity in mice. Microbes Infect. 2025 Mar-Apr; 27(3):105463.
-
Tanner T, Medhavi FNU, Richardson S, Omosun YO, Eko FO. In silico design and analysis of a multiepitope vaccine against Chlamydia. Pathog Dis. 2024 02 07; 82.
-
Elder H, Platt L, Leach D, Sheetoh C, Ramirez VM, Molotnikov L, Hernandez B, Roosevelt K, Hsu KK. Factors Associated With Delays in Presentation and Treatment of Gonorrhea, Massachusetts 2015-2019. Sex Transm Dis. 2024 03 01; 51(3):146-155.
-
Richardson S, Bell CR, Medhavi F, Tanner T, Lundy S, Omosun Y, Igietseme JU, Eko FO. A novel cold-chain free VCG-based subunit vaccine protects against Chlamydia abortus-induced neonatal mortality in a pregnant mouse model. Front Immunol. 2023; 14:1243743.
-
Zhao L, Lundy SR, Eko FO, Igietseme JU, Omosun YO. Genital tract microbiome dynamics are associated with time of Chlamydia infection in mice. Sci Rep. 2023 06 02; 13(1):9006.
-
Cheong HC, Cheok YY, Chan YT, Tang TF, Sulaiman S, Looi CY, Gupta R, Arulanandam B, Chang LY, Wong WF. Chlamydia trachomatis plasmid-encoding Pgp3 protein induces secretion of distinct inflammatory signatures from HeLa cervical epithelial cells. BMC Microbiol. 2023 03 04; 23(1):58.
-
Chan YT, Cheok YY, Cheong HC, Tan GMY, Seow SR, Tang TF, Sulaiman S, Looi CY, Gupta R, Arulanandam B, Wong WF. Influx of podoplanin-expressing inflammatory macrophages into the genital tract following Chlamydia?infection. Immunol Cell Biol. 2023 04; 101(4):305-320.
-
Tian Q, Zhou Z, Wang L, Sun X, Arulanandam B, Xu D, Xue M, Zhong G. Gastrointestinal Chlamydia-Induced CD8+ T Cells Promote Chlamydial Pathogenicity in the Female Upper Genital Tract. Infect Immun. 2021 09 16; 89(10):e0020521.
-
Richardson S, Medhavi F, Tanner T, Lundy S, Omosun Y, Igietseme JU, Carroll D, Eko FO. Cellular Basis for the Enhanced Efficacy of the Fms-Like Tyrosine Kinase 3 Ligand (FL) Adjuvanted VCG-Based Chlamydia abortus Vaccine. Front Immunol. 2021; 12:698737.